Inotek Plummets On Glaucoma Phase III Failure

 
• By Alexandra Shimmings

Shares in Inotek Pharmaceuticals went into freefall on Jan. 3 on news that its lead product had failed in a Phase III trial in glaucoma patients.

close up of an eye
• Source: Shutterstock

More from Clinical Trials

More from R&D